Find Relief with Spravato (Esketamine) for Treatment-Resistant Depression and Major Depressive Disorder

At Klarisana, we are proud to offer Spravato (esketamine) treatment, a groundbreaking option for those struggling with treatment-resistant depression. Spravato is an FDA-approved nasal spray, covered by insurance, that works differently from traditional antidepressants, offering rapid relief for those who haven’t responded to other treatments. Administered under the careful supervision of our experienced medical team, Spravato is a vital part of our holistic approach to mental health care.

How Spravato Fits into Our Holistic Care Model

At Klarisana, we believe that true healing comes from integrating various therapeutic approaches. Our services are designed to work together to provide comprehensive care, ensuring that every aspect of your mental health is addressed. Here’s how Spravato works within our holistic care model:

1. Preparation and Initial Assessment

Before beginning Spravato treatment, you’ll meet with our Medical Intake Team for an evaluation. This process ensures that you meet the necessary criteria for treatment.

2. During Treatment

Your Spravato sessions will take place in one of our private and calming treatment rooms, where you will be supported by our compassionate Clinical Team. The team will ensure your comfort and safety throughout the treatment process, providing the guidance you need to navigate this transformative experience. 

3. Integration and Post-Treatment Support

After your sessions, our experienced providers are available to support you in your mental wellness journey.  This may include options such as follow-up integration sessions, talk therapy, and other therapeutic modalities to help you process your experiences and set new goals for your mental health journey. 

4. Time Commitment and Long-Term Maintenance 

During your Spravato treatment, you’ll spend approximately 2 hours in one of our treatment rooms, where our team will closely monitor your vital signs, including blood pressure. It’s important to note that you’ll need someone to drive you home, as you won’t be able to drive yourself after the treatment. 

For treatment-resistant depression (TRD), you’ll come in for treatment twice a week during the first 4 weeks. From weeks 5-8, your visits will decrease to once a week. After week 9, your sessions will be scheduled once a week or once every two weeks, depending on your clinician’s recommendation.

For (MDD) with suicidal thoughts or actions, the initial treatment schedule also involves twice-weekly sessions for the first 4 weeks. The need for ongoing treatment will be assessed after this initial period.

Safety results from the long-term SUSTAIN-3 trial, which tracked patients for up to 6 years, were consistent with the safety and tolerability profile established in earlier studies. Additionally, data from a long-term, open-label safety study showed that MADRS scores (which measure the severity of depression symptoms) remained steady over the course of 5.1 years.

This means that research has shown that Spravato remains safe and effective for long-term use, helping to maintain improvements in depression symptoms for many years.

Why Choose Spravato at Klarisana?

• Covered by Insurance: Spravato is covered by many major insurance providers, making this innovative treatment more accessible and affordable for individuals suffering from treatment-resistant depression.
• FDA Approved:The first and only FDA-approved therapy for treatment-resistant depression that works differently than other available options.
• Experienced Team: Our medical and behavioral health professionals are dedicated to providing compassionate, personalized care every step of the way.
• Rapid Relief: Many patients experience significant improvement in their symptoms within a few sessions, with rapid and superior improvement at Week 4. Notably, the most treatment difference is observed at 24 hours compared to placebo plus oral antidepressant.

How Soon Can I Be Seen?

Spravato treatment will be available this Fall. To get started, simply submit a contact form to join our waitlist, and we’ll reach out to schedule your consultation as soon as availability opens up.

Get Started with Spravato at Klarisana

If you’re struggling with Treatment-Resistant Depression or Major Depressive Disorder with suicidal thoughts or actions, Spravato could be the solution you’ve been searching for. Take the first step towards healing by scheduling a consultation with our team. Our Patient Engagement Team is ready to assist you with any questions you may have and guide you through the process.